Breast Cancer Aid Fund Launches to Save Lives

"Ruijin - Häagen-Dazs Breast Cancer Aid Fund” was launched in November, 2009.

November 3, 2009

Impoverished patients can apply for financial aid from now on through online application on www.breastcanceraid.com.cn or on-site application in Shanghai Ruijin Hospital.

This Breast Cancer Aid Fund is jointly established by Häagen-Dazs, Shanghai Ruijin Hospital, Shanghai Charity Foundation and Shanghai Charitable Cancer Research Center. The fund aims to help the impoverished patients complete surgery and related treatments, as well as raise the public awareness of breast cancer prevention and treatment.

The Web site www.breastcanceraid.com.cn also went live at the same time. It is the first breast cancer care website in China that offers online aid application together with comprehensive information on this disease. People can acquire knowledge for breast cancer prevention, diagnosis, treatment, nursing and the latest progress on breast cancer R&D on this platform. Patients can interact with KOLs online and share their own stories to encourage more.

Breast cancer is one of the most common types of cancer among women in China. It has become the top killer for women in cities. 90 percent of patients can be cured through early diagnosis and early treatment. However, many patients may not discover the tumor until late stage. Some patients who cannot afford a complete treatment have to give up the surgery, just waiting and suffering. Therefore, it is of great importance to help the patients in difficulty receive timely treatment, giving them a chance to live, and to educate the public for breast cancer prevention.

“Love is the long-lasting theme for Häagen-Dazs. Family love is an important part.” Gary Chu, Senior Vice President of General Mills and President of Greater China, said, “Mothers are the world’s greatest. It is painful to know that many mothers die every year from breast cancer. We will work together with Ruijin Hospital to make contributions to breast cancer prevention, treatment and research.”